The VITAL Amyloidosis Study: A Randomized, Double-Blind, Placebo-Controlled, Global, Phase 3 Study of NEOD001 in Patients with AL Amyloidosis and Cardiac Dysfunction
暂无分享,去创建一个
M. Liedtke | M. Gertz | G. Merlini | J. Zonder | M. Koller | B. Weiss | V. Sanchorawala | R. Comenzo | H. Landau | J. Walling | G. Kinney